FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approved a supplemental application for RETROVIR (zidovudine) from ViiV Healthcare Company, potentially leading to labeling changes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• RETROVIR (Zidovudine)

Snippet

SUPPL AP for RETROVIR (ZIDOVUDINE)